Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma

This publication has 11 references indexed in Scilit:

• Neuroblastoma Cells Isolated from Bone Marrow Metastases Contain a Naturally Enriched Tumor-Initiating Cell
  Cancer Research, 2007
• Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET
  European Journal Of Cancer, 2007
• Tumor cell Dynamics and Metastasis in Advanced Neuroblastoma
  Pediatric Surgery International, 2005
• Detection and treatment of minimal residual disease in high‐risk neuroblastoma
  Pediatric Transplantation, 2004
• Quantitation of GD2 Synthase mRNA by Real-Time Reverse Transcriptase Polymerase Chain Reaction: Clinical Utility in Evaluating Adjuvant Therapy in Neuroblastoma
  Journal of Clinical Oncology, 2003
• Disease Outcome May Be Predicted by Molecular Detection of Minimal Residual Disease in Bone Marrow in Advanced Neuroblastoma: A Pilot Study
  Journal of Pediatric Hematology/Oncology, 2001
• MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
  Journal of Clinical Oncology, 2000
• Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction
  Journal of Pediatric Surgery, 1997
• Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
  Journal of Clinical Oncology, 1993
• Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the study group of Japan
  Cancer, 1990